BackgroundFew data exist on regional systems of care for the treatment of ST‐segment–elevation myocardial infarction (STEMI) in developing countries. Our objective was to describe temporal trends in 30‐day mortality and identify predictors of mortality among STEMI patients enrolled in a prospective registry in Brazil.Methods and ResultsFrom January 2011 to June 2013, 520 patients who received initial STEMI care at 23 nonspecialized public health units or hospitals, some of whom were transferred to a public cardiology referral center, were identified through a regional STEMI network supported by telemedicine and the local prehospital emergency medical service. We stratified patients into five 6‐month periods based on presentation date. Mean age (±SD) of patients was 62.0 (±12.2) years, and 55.6% were men. The mean Global Registry of Acute Coronary Events (GRACE) score was 145 (±34). Overall mortality at 30 days was 15.0%. Use of dual antiplatelet therapy and statins increased significantly from baseline (January 2011) to period 5 (June 2013): 61.8% to 93.6% (P<0.001) and 60.4% to 79.7% (P<0.001), respectively. Rates of primary reperfusion also increased (29.1%–53.8%; P<0.001), and more patients were transferred to the referral center (44.7%–76.3%; P=0.001). Thirty‐day mortality rates decreased from 19.8% to 5.1% (P<0.001). In multivariable analysis, factors independently associated with 30‐day mortality were higher GRACE score, history of previous stroke, lack of transfer to the referral center, and lack of use of optimized medical therapy.ConclusionsImplementation of a regional STEMI system was associated with lower mortality and higher use of evidence‐based therapies.
Nota: Estas diretrizes se prestam a informar e não a substituir o julgamento clínico do médico que, em última análise, deve determinar o tratamento apropriado para seus pacientes.
BackgroundThere is a physiologic elevation of total cholesterol (TC) and triglycerides
(TG) during pregnancy. Some authors define dyslipidemia (DLP) in pregnant
women when TC, LDL and TG concentrations are above the 95th percentile
(p95%) and HDL concentration is below the 5th percentile (P5%) for
gestational age (GA).ObjectiveTo compare the prevalence of DLP in pregnant women using percentiles criteria
with the V Brazilian Guidelines on Dyslipidemia and the association with
maternal and fetal outcomes.ResultsPregnant women with high-risk conditions, aged 18-50 years, and at least one
lipid profile during pregnancy was classified as the presence of DLP by two
diagnostic criteria. Clinical and laboratorial data of mothers and newborns
were evaluated.Conclusion433 pregnant women aged 32.9 ± 6.5 years were studied. Most (54.6%)
had lipid profile collected during third trimester. The prevalence of any
lipid abnormalities according to the criteria of the National Guidelines was
83.8%: TC ≥ 200 mg/dL was found in 49.9%; LDL ≥ 160 mg/dL, in
14.3%, HDL ≤ 50 mg/dL in 44.4% and TG ≥ 150 mg/dL in 65.3%.
Any changes of lipid according to percentiles criteria was found in 19.6%:
elevation above the P95% for TC was found in 0.7%; for LDL, 1.7%; for TG
6.4% and HDL lower than the P5% in 13%. The frequency of comorbidity:
hypertension, diabetes, smoking, obesity and preeclampsia was similar among
pregnant women when DLP was compared by both criteria.ConclusionThe prevalence of DLP during pregnancy varies significantly depending on the
criteria used, however none demonstrated superiority in association with
comorbidities.
INTRODUÇÃO: Os portadores de diabetes melito tipo 1 (DM1) possuem aumentado risco de doença cardiovascular e, ainda assim, podem apresentar perfil lipídico normal. Para esclarecer se os níveis normais de HDL podem ocultar defeitos na função, foram estudados a transferência de lípides para a HDL em DM1. MÉTODOS: Vinte e uma mulheres jovens portadoras de DM1 foram comparadas com 21 mulheres não-diabéticas. Nanoemulsões foram usadas como doadoras de lípides para HDL: uma marcada com ³H-triglicérides e 14C-colesterol livre e outra com ³H-éster de colesterol e 14C-fosfolípides. Após 1 hora de incubação com amostras de plasma, seguida por precipitação química, o sobrenadante, contendo HDL, teve a radioatividade contada. RESULTADOS: Nenhuma diferença foi encontrada nas transferências dos ésteres de colesterol, triglicérides, colesterol livre e fosfolípides para as HDL. CONCLUSÃO: A transferência de lípides para a HDL não está afetada em portadoras de DM1. Isso sugere que a doença não altera a composição de lipoproteínas e a ação de proteínas de transferência.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.